Skip to main content
Day.News — Local News. Real Community.
COLUMBUS DAY NEWS
Local News. Real Community.
health
1 min read

Supreme Court Rules for Roundup Manufacturer in Cancer Case

The Supreme Court sided with the herbicide manufacturer in a case brought by a Missouri man who attributed his cancer to Roundup exposure. The ruling is expected to impact thousands of similar cases across the country.

07/18/2026 · Texas edition

Advertisement

Advertisement

Why it matters locally: The Supreme Court's decision limiting liability for Roundup's manufacturer could have significant implications for Texas's agricultural sector and its large farming community, potentially impacting ongoing or future litigation efforts by farmers, landscapers, and homeowners who have used the herbicide. The ruling also affects the legal landscape for product liability claims statewide, setting a precedent that makes it more challenging for plaintiffs to pursue similar cases in Texas courts.

The Supreme Court voted 7-2 to overturn a jury award in a case where a Missouri man claimed that exposure to Roundup caused his cancer. The decision favored the herbicide's manufacturer and is expected to affect the viability of thousands of pending lawsuits filed in courts nationwide. The jury had previously awarded the plaintiff compensation. The Supreme Court's majority opinion reversed that judgment, altering the legal standards that govern such claims. Dr. Chadi Nabhan, who authored a book examining the Monsanto trials and litigation over the herbicide, discussed the ruling's implications. Nabhan has written extensively on the legal battles surrounding Roundup exposure claims. Scientific research on the herbicide's health effects has produced conflicting findings. The International Agency for Research on Cancer classified glyphosate, Roundup's active ingredient, as probably carcinogenic in 2015. The U.S. Environmental Protection Agency reached a different conclusion in 2020, stating the chemical was unlikely to pose a cancer risk to humans at the exposure levels Americans typically encounter. Farmers, landscapers and homeowners have used Roundup for decades as a broad-spectrum herbicide. The product became one of the world's most widely used agricultural chemicals after its introduction in the 1970s. Plaintiffs in the litigation attributed their cancers to occupational or residential contact with the herbicide. They sought compensation from the manufacturer based on allegations that the company failed to adequately warn consumers about potential health risks. The court's decision removes a major avenue for additional lawsuits to proceed. Legal experts said the ruling sets a precedent that will make it substantially harder for future plaintiffs to bring similar cases to trial.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

How do you feel about this story?

NA

National Desk

Trust 3.1104047 articles8,231,170 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

Join the conversation

Sign in to share your thoughts, reply to readers, and like comments.

Sign in to comment
Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Trending stories will appear here.

More from Texas

No other local stories are available right now.

Events & Things to Do

Read section →

Upcoming events will appear here.

Advertisement

Advertisement

Keep Reading

Related Stories

More health stories from Texas

health

Tennessee Inmate Takes Steps After Botched Execution

Christa Pike, a Tennessee inmate, reportedly took steps in her hospital room six days after receiving two lethal injections. This development has initiated further discussion surrounding capital punishment procedures. Austin Sarat, author of 'Lethal Injection and the False Promise of Humane Execution,' discussed the issue.

Read Story →
health

Discussion Addresses Mental Health, Suicide Trends in Black Community

NPR's Michel Martin hosted a panel discussion on mental health and suicide within the Black community. The conversation explored the subject through personal perspectives. Participants shared individual experiences.

Read Story →
health

FDA to Conclude Abortion Pill Safety Review by March

The Food and Drug Administration (FDA) will finalize its safety review of mifepristone in March. A Louisiana federal judge mandated this update as part of a legal challenge seeking to reverse a policy allowing mail delivery of the abortion medication.

Read Story →
health

GLP-1 Medications Show Potential in Addressing Addiction

New evidence suggests GLP-1 drugs, commonly used for diabetes and weight loss, may also reduce cravings for addictive substances. Scientists are conducting studies to determine if these medications can help individuals with substance use disorders. This research explores a potential new application for GLP-1s in public health.

Read Story →
health

Report Examines Impact of Trump Administration's Drug Pricing Initiatives

A recent report evaluated the Trump administration's claims regarding drug prices, including the effectiveness of TrumpRx discounts. Findings indicate a mixed impact on prescription drug costs for consumers. The administration has asserted that the U.S. now pays the world's lowest drug prices.

Read Story →
health

Cost of GLP-1 Medications Prompts Search for Alternatives

Many Americans face financial hurdles when trying to access GLP-1 medications. These cost barriers have prompted some patients to seek out alternative, unregulated versions. The situation highlights ongoing challenges in prescription drug affordability.

Read Story →
Scroll for more stories